mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
1 |
0.0002 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0002 |